Prescott Joseph, Falzarano Darryl, Feldmann Heinz
Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana.
J Infect Dis. 2015 Oct 1;212 Suppl 2(Suppl 2):S271-6. doi: 10.1093/infdis/jiv203. Epub 2015 May 5.
Most ebolaviruses can cause severe disease in humans and other primates, with high case fatality rates during human outbreaks. Although these viruses have been studied for almost 4 decades, little is know regarding the mechanisms by which they cause disease and what is important for protection or treatment after infection. Because of the sporadic nature of the outbreaks and difficulties accessing the populations affected by ebolaviruses, little is also known about what constitutes an appropriate immune response to infection in humans that survive infection. Such knowledge would allow a targeted approach to therapies. In contrast to humans, rodents are protected from disease on infection with ebolaviruses, although adapted versions of some of the viruses are lethal in mice, hamsters and guinea pigs. Using the recently described hamster model, along with T-cell depletion strategies, we show that CD4(+) T cells are required for natural immunity to Ebola virus infection and that CD4-dependent antibody responses are required for immunity in this model.
大多数埃博拉病毒可在人类和其他灵长类动物中引发严重疾病,在人类疫情爆发期间病死率很高。尽管对这些病毒的研究已近40年,但对于它们致病的机制以及感染后保护或治疗的关键因素仍知之甚少。由于疫情爆发具有散发性,且难以接触到受埃博拉病毒影响的人群,对于感染后存活的人类而言,何种免疫反应才是对感染的适当反应也所知甚少。此类知识将有助于采取有针对性的治疗方法。与人类不同,啮齿动物感染埃博拉病毒后不会患病,不过某些病毒的适应株对小鼠、仓鼠和豚鼠是致命的。利用最近描述的仓鼠模型以及T细胞耗竭策略,我们发现CD4(+) T细胞是埃博拉病毒感染天然免疫所必需的,并且在该模型中,免疫需要依赖CD4的抗体反应。